Phylogenomics of Mycobacterium africanum reveals a new lineage and a complex evolutionary history by Coscolla, Mireia et al.








Phylogenomics of Mycobacterium africanum reveals a new lineage and a
complex evolutionary history
Coscolla, Mireia ; Gagneux, Sebastien ; Menardo, Fabrizio ; Loiseau, Chloé ; Ruiz-Rodriguez, Paula ;
Borrell, Sonia ; et al ; Fenner, Lukas ; Böttger, Erik C
Abstract: Human tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex
(MTBC). The MTBC comprises several human-adapted lineages known as M. tuberculosis sensu stricto,
as well as two lineages (L5 and L6) traditionally referred to as Mycobacterium africanum. Strains of
L5 and L6 are largely limited to West Africa for reasons unknown, and little is known of their genomic
diversity, phylogeography and evolution. Here, we analysed the genomes of 350 L5 and 320 L6 strains,
isolated from patients from 21 African countries, plus 5 related genomes that had not been classified into
any of the known MTBC lineages. Our population genomic and phylogeographical analyses showed that
the unclassified genomes belonged to a new group that we propose to name MTBC lineage 9 (L9). While
the most likely ancestral distribution of L9 was predicted to be East Africa, the most likely ancestral
distribution for both L5 and L6 was the Eastern part of West Africa. Moreover, we found important
differences between L5 and L6 strains with respect to their phylogeographical substructure and genetic
diversity. Finally, we could not confirm the previous association of drug-resistance markers with lineage
and sublineages. Instead, our results indicate that the association of drug resistance with lineage is most
likely driven by sample bias or geography. In conclusion, our study sheds new light onto the genomic
diversity and evolutionary history of M. africanum, and highlights the need to consider the particularities
of each MTBC lineage for understanding the ecology and epidemiology of TB in Africa and globally.
DOI: https://doi.org/10.1099/mgen.0.000477






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Coscolla, Mireia; Gagneux, Sebastien; Menardo, Fabrizio; Loiseau, Chloé; Ruiz-Rodriguez, Paula; Borrell,
Sonia; et al; Fenner, Lukas; Böttger, Erik C (2021). Phylogenomics of Mycobacterium africanum reveals





Phylogenomics of Mycobacterium africanum reveals a new 
lineage and a complex evolutionary history
Mireia Coscolla1,*, Sebastien Gagneux2,3, Fabrizio Menardo2,3, Chloé Loiseau2,3, Paula Ruiz- Rodriguez1, Sonia Borrell2,3, 
Isaac Darko Otchere4, Adwoa Asante- Poku4, Prince Asare4, Leonor Sánchez- Busó5,6, Florian Gehre7,8, C. 
N’Dira Sanoussi9,10, Martin Antonio11, Dissou Affolabi9, Janet Fyfe12, Patrick Beckert13,14, Stefan Niemann13,14, Abraham 
S. Alabi15, Martin P. Grobusch15,16,17, Robin Kobbe18, Julian Parkhill19, Christian Beisel20, Lukas Fenner21, Erik C. Böttger22, 
Conor J. Meehan23, Simon R. Harris6,24, Bouke C. de Jong10, Dorothy Yeboah- Manu4 and Daniela Brites2,3
RESEARCH ARTICLE
Coscolla et al., Microbial Genomics 2021;7:000477
DOI 10.1099/mgen.0.000477
Received 25 June 2020; Accepted 29 October 2020; Published 08 February 2021
Author affiliations: 1I2SysBio, University of Valencia- FISABIO Joint Unit, Valencia, Spain; 2Swiss Tropical and Public Health Institute, Basel, Switzerland; 
3University of Basel, Basel, Switzerland; 4Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana; 5Centre for 
Genomic Pathogen Surveillance, Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 6Wellcome Sanger Institute, 
Wellcome Genome Campus, Cambridge, UK; 7Infectious Disease Epidemiology Department, Bernhard- Nocht- Institute for Tropical Medicine, Hamburg, 
Germany; 8Health Department, East African Community (EAC), Arusha, Tanzania; 9Laboratoire de Référence des Mycobactéries, Ministry of Health, 
Cotonou, Bénin; 10Mycobacteriology Unit, Institute of Tropical Medicine, Antwerp, Belgium; 11London School of Hygiene and Tropical Medicine, London, 
UK; 12Mycobacterium Reference Laboratory, Victoria Infectious Diseases Reference Laboratory, Peter Doherty Institute, Melbourne, Victoria, Australia; 
13Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany; 14Partner Site Hamburg- Lübeck- Borstel- Riems, German 
Center for Infection Research, Borstel, Germany; 15Centre de Recherches Médicales en Lambaréné (Cermel), Lambaréné, Gabon; 16Institut für 
Tropenmedizin, Deutsches Zentrum fuer Infektionsforschung, University of Tübingen, Tübingen, Germany; 17Center of Tropical Medicine and Travel 
Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam Infection and Immunity, Amsterdam Public Health, 
University of Amsterdam, Amsterdam, The Netherlands; 18First Department of Medicine, Division of Infectious Diseases, University Medical Center 
Hamburg- Eppendorf, Germany; 19Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, UK; 20Department of 
Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland; 21Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; 
22Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland; 23School of Chemistry and Biosciences, University of Bradford, Bradford, 
UK; 24Microbiotica Limited, Bioinnovation Centre, Wellcome Genome Campus, Cambridge, CB10 1DR, UK.
*Correspondence: Mireia Coscolla,  mireia. coscolla@ uv. es
Keywords: diversity; evolution; genome; mycobacteria; Mycobacterium africanum; Mycobacterium tuberculosis.
Abbreviations: CI, confidence interval; DEC, dispersal- extinction- cladogenesis; FST, fixation index; MTBC, Mycobacterium tuberculosis complex; OR, 
odds ratio; PCA, principal component analysis; RD, region of difference; TB, tuberculosis.
All raw data generated for this study have been submitted to the European Nucleotide Archive (ENA; https://www. ebi. ac. uk/ ena/) under the study 
accession numbers PRJEB9003, PRJEB38656, PRJEB4884, PRJEB38317, PRJEB31139, PRJEB6273 and PRJEB31144. Individual run accession 
numbers for new and published sequences are indicated in Table S1.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary data files. Two supplementary 
figures and nine supplementary tables are available with the online version of this article.
000477 © 2021 The Authors
This is an open- access article distributed under the terms of the Creative Commons Attribution License.
Abstract
Human tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). The MTBC comprises 
several human- adapted lineages known as M. tuberculosis sensu stricto, as well as two lineages (L5 and L6) traditionally 
referred to as Mycobacterium africanum. Strains of L5 and L6 are largely limited to West Africa for reasons unknown, and little 
is known of their genomic diversity, phylogeography and evolution. Here, we analysed the genomes of 350 L5 and 320 L6 strains, 
isolated from patients from 21 African countries, plus 5 related genomes that had not been classified into any of the known 
MTBC lineages. Our population genomic and phylogeographical analyses showed that the unclassified genomes belonged to a 
new group that we propose to name MTBC lineage 9 (L9). While the most likely ancestral distribution of L9 was predicted to be 
East Africa, the most likely ancestral distribution for both L5 and L6 was the Eastern part of West Africa. Moreover, we found 
important differences between L5 and L6 strains with respect to their phylogeographical substructure and genetic diversity. 
Finally, we could not confirm the previous association of drug- resistance markers with lineage and sublineages. Instead, our 
results indicate that the association of drug resistance with lineage is most likely driven by sample bias or geography. In conclu-
sion, our study sheds new light onto the genomic diversity and evolutionary history of M. africanum, and highlights the need to 
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INTRODUCTION
Tuberculosis (TB) causes more human deaths than any other 
infectious disease, and it is among the top ten causes of death 
worldwide [1]. Among the 30 high TB burden countries, half 
are in sub- Saharan Africa [1]. TB in humans and animals is 
caused by the Mycobacterium tuberculosis complex (MTBC) 
[2], which includes different lineages, some referred to as 
M. tuberculosis sensu stricto (lineage 1 to lineage 4 and lineage 
7), others as Mycobacterium africanum (lineage 5 and lineage 6), 
a recently discovered lineage 8 [3], as well as different animal- 
associated ecotypes such as Mycobacterium bovis, Mycobacte-
rium pinnipedii or Mycobacterium microti among others [4, 5]. 
Some lineages are geographically widespread, while others are 
more restricted [6]. The latter is particularly the case for lineage 
7 (L7), which is limited to the Horn of Africa [7, 8], and L5 and 
L6, which are mainly found in West Africa [9]. L5 and L6 show a 
prevalence of up to 50 % among smear- positive TB cases in some 
West African countries [10–13]. Hence, L5 and L6 contribute 
significantly to the overall burden of TB across sub- Saharan 
Africa. Compared to the other MTBC lineages, relatively little 
is known with regard to the ecology and evolution of L5 and 
L6 [5, 14]. Two studies have found L5 to be associated with 
Ewe ethnicity in Ghana [15, 16], supporting the notion that this 
lineage might be locally adapted to this particular human popu-
lation [17]. Several epidemiological associations suggest that 
L6 might be attenuated for developing disease as compared to 
other lineages (see De Jong et al. [9] for a review). For example, 
L6 has been associated with slower progression from infec-
tion to disease [14] and with human immunodeficiency virus 
co- infection [14, 16], although conflicting data exist [18, 19].
L5 and L6 differ substantially from other MTBC lineages with 
respect to in vitro growth and metabolism [20–25], and in 
various molecular features relevant for patient diagnosis, such 
as a non- synonymous mutation in the MPT64 antigen [26] 
and reduced T cell response to ESAT6 [27]. Mycobacterial 
genetic determinants are also implicated in virulence and 
immunogenicity in M. africanum [22, 23]. To shed more light 
on the population genetics, phylogeography and evolutionary 
history of M. africanum, we analysed the largest set of whole- 
genome data for L5 and L6 generated to date.
METHODS
M. africanum dataset
We analysed 675 genomes to determine the genetic diversity, 
phylogeography and population structure of M. africanum 
(Table S1, available with the online version of this article). 
Geographical origin was determined as the country of origin 
of the patient and when not available the country of isola-
tion. Because the number of different countries was too high 
to be shown clearly in the figures, and some of them only 
included very few genomes, we grouped countries together 
into five African regions following the definitions of Gehre et 
al. [28]: three big regions South, East and Central Africa, and 
two regions within West Africa, where most of the isolates 
come from. The western part of West Africa includes Gambia, 
Senegal, Mauritania, Sierra Leone, Liberia, Guinea, Ivory 
Coast and Mali, while the Eastern part of West Africa includes 
Ghana, Nigeria, Benin Niger, Burkina Faso. African maps 
were built using Mapchart (https:// mapchart. net/ africa. html)
Bacterial culture, DNA extraction and whole-
genome sequencing
Archived MTBC isolates were revived by sub- culturing on 
Löwenstein–Jensen medium slants supplemented with 0.4 % 
sodium pyruvate or with 0.3 % glycerol to enhance the growth 
of the different lineages and incubated at 37 °C. Five loops full 
of colonies were harvested at the late exponential phase into 
2 ml cryo- vials containing 1 ml sterile nuclease- free water, 
inactivated at 98 °C for 60 min for DNA extraction using the 
previously described hybrid DNA extraction method [29]. 
Impact Statement
The understanding of Mycobacterium tuberculosis 
genomic diversity and its evolution in Africa, particularly 
lineage 5 and 6 known as Mycobacterium africanum, lags 
behind our knowledge of other lineages from Europe, 
North America and Asia. This study fills a research gap 
in M. tuberculosis diversity in Africa, focusing on M. afri-
canum lineages, population structure and phylogeog-
raphy. We have revealed a new lineage (Lineage 9) within 
M. africanum that, unlike the other M. africanum lineages, 
is distributed in East Africa. This finding, together with 
the recently new lineage found in Central Africa (Lineage 
8), starts revealing the hidden diversity of M. tuberculosis 
in Africa. Additionally, our results have provided useful 
tools for further study of M. africanum, including a better 
understanding of the population structure and robust 
genetic markers to differentiate lineages and subline-
ages. Finally, this study has facilitated the inclusion of a 
strain of the newly described Lineage 9 in a public collec-
tion to further facilitate its biological characterization.
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The MTBC lineages were then confirmed by spoligotyping 
and long- sequence polymorphisms and sent for whole- 
genome sequencing.
The MTBC isolates were grown in 7H9- Tween (0.05 %) 
medium (BD) ±40 mM sodium pyruvate. We extracted 
genomic DNA after harvesting the bacterial cultures in the 
late exponential phase of growth using the CTAB (N- cetyl- 
N,N,N- trimethylammonium bromide) method [30].
Sequencing libraries were prepared using a Nextera XT DNA 
preparation kit (Illumina). Multiplexed libraries were paired-
 end sequenced on the Illumina HiSeq 2500 (Illumina) system 
with 151 or 101 cycles when sequenced at the Genomics 
Facility, ETH Zürich, Basel (Switzerland), HiSeq 2500 (100 bp, 
paired end) when sequenced at the Wellcome Sanger Institute, 
or on Illumina MiSeq (250 and 300 bp, paired end) or NextSeq 
(150 bp, paired end) according to the manufacturer’s instruc-
tions (Illumina) when sequenced at the genomics facilities at 
the Research Center Borstel (Germany).
Bioinformatics analysis
Mapping and variant calling of Illumina reads
The fastq files obtained were processed with Trimmomatic 
v 0.33 (slidingwindow 5 : 20) [31] to clip Illumina adaptors 
and trim low- quality reads. Any reads shorter than 20 bp were 
excluded for the downstream analysis. Overlapping paired-
 end reads of 15 nucleotides size were merged with SeqPrep v1.2 
(https:// github. com/ jstjohn/ SeqPrep). We used bwa v 0.7.13 
(mem algorithm) [32] to align the resultant reads to the recon-
structed ancestral sequence of M. tuberculosis obtained by 
Comas et al. [33]. Duplicated reads were marked by the Mark 
Duplicates module of Picard v 2.9.1 (https:// github. com/ broa-
dinstitute/ picard) and excluded. To avoid false- positive calls, 
Pysam v 0.9.0 (https:// github. com/ pysam- developers/ pysam) 
was used to exclude reads with an alignment score lower than 
(0.93×read_length)−(read_length×4×0.07), corresponding to 
more than seven mismatches per 100 bp. SNPs were called 
with SAMtools v 1.2 mpileup [34] and VarScan v 2.4.1 [35] 
using the following thresholds: minimum mapping quality of 
20, minimum base quality at a position of 20, minimum read 
depth at a position of 7× and without strand bias. Only SNPs 
considered to have reached fixation within an isolate were 
considered (at a within- host frequency of ≥90 %). Conversely, 
when the within- isolate SNP frequency was ≤10 % the ancestor 
state was called. Mixed infections or contaminations were 
discarded by excluding genomes with more than 1000 vari-
able positions with within- host frequencies between 90 and 
10 % and genomes for which the number of within- host SNPs 
was higher than the number of fixed SNPs. Additionally, we 
excluded genomes with mean read depth <15× (after all the 
referred filtering steps). All SNPs were annotated using snpEff 
v4.11 [36], in accordance with the M. tuberculosis H37Rv 
reference annotation (NC_000962.3). SNPs falling in regions 
such as PPE and PE- PGRS, phages, insertion sequences and 
in regions with at least 50 bp identities to other regions in the 
genome were excluded from the analysis, as in the paper by 
Stucki et al. [37]. Customized scripts were used to calculate 
mean coverages per gene corrected by the size of the gene. 
Gene deletions were determined as regions with no coverage 
to the reference genome.
Phylogenetic reconstruction and ancestry estimation
All 675 genomes were used to produce an alignment 
containing only polymorphic sites. The alignment was used 
to infer a maximum- likelihood phylogenetic tree using the 
mpi parallel version of RAxML [38]. We used the general time 
reversible model of nucleotide substitution under the gamma 
model of rate heterogeneity and performed 1000 alternative 
runs on distinct starting trees combined with rapid bootstrap 
inference. To correct the likelihood for ascertainment bias 
introduced by only using polymorphic sites, we used Lewis 
correction [39]. The software Treemmer [40] was used to 
remove redundancy in the collection of 675 whole- genome 
SNP alignments with the stop option - RTL 0.95, i.e. keeping 
95 % of the original tree length. The resulting reduced dataset 
of 424 genomes was kept for subsequent analysis. First, we 
used the reduced dataset plus a collection of 35 representative 
animal genomes to produce an alignment containing only 
polymorphic sites and inferred a maximum- likelihood phylo-
genetic tree as described above. The best- scoring maximum- 
likelihood topology is shown. The phylogeny was rooted 
using 'Mycobacterium canettii'. The topology was annotated 
and coloured using the package ggtree [41] from R [42] and 
InkScape.
We inferred the biogeographical histories of L5 and L6 using 
statistical- dispersal analysis (s- diva) and the Bayesian binary 
Markov chain Monte Carlo (BBM) method for ancestral state, 
dispersal- extinction- cladogenesis (DEC), and Bayesian infer-
ence for discrete areas (BayArea) implemented in rasp v4.0 
[43]. Because we did not have the geographical origin of 18 
samples, we used a phylogeny containing only samples from 
Africa where the isolation or place of birth of the patient 
was known. The possible ancestral ranges at each node on 
a selected tree were obtained. For s- diva, the number of 
maximum areas was kept as two. For BBM analysis, chains 
were run simultaneously for 500 000 generations. The state 
was sampled every 100 generations. Estimated Felsenstein 
1981 + gamma was used with null root distribution.
Population structure and genetic diversity
Genetic structure indices and corrected pairwise SNP differ-
ences between the five African regions where genomes are 
grouped (Western West Africa, Eastern West Africa, Central 
Africa, South Africa and East Africa) were calculated using 
Analysis of MOlecular VAriance (AMOVA) using information 
on the allelic content of haplotypes, as well as their frequencies 
implemented in Arlequin v3.5.2.2 [44]. The significance of the 
covariance components was tested using 20 000 permutations 
by non- parametric permutation procedures.
Pairwise SNP differences and mean nucleotide diversity 
per site (π) were calculated using the R package ape [45]. π 
was calculated as the mean number of pairwise mismatches 
among L5 and L6 divided by the total length of queried 
genome base pairs, which comprise the total length of the 
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genome after excluding repetitive regions (see above) [46]. 
Confidence intervals (CIs) for π were obtained by bootstrap-
ping (1000 replicates) by re- sampling with replacement the 
nucleotide sites of the original alignments of polymorphic 
positions using the function sample in R [42]. Lower and 
upper levels of confidence were obtained by calculating the 
2.5th and the 97.5th quantiles of the π distribution obtained 
by bootstrapping. Population structure was evaluated using 
principal component analysis (PCA) on SNP differences 
using R Package adegenet [47] and plotted using the plot 
function in R.
To further explore geographical structure, we evaluated the 
relation between the genomic phylogeny and the geographical 
origin of the genomes for each lineage separately using linear 
axis analysis in GenGIS v2.2.2 [48]. The default GenGIS 
Africa map was used and a maximum- likelihood phyloge-
netic tree was reconstructed from whole genome SNPs as 
described above for each lineage separately. A linear axis 
plot (10 000 permutations) was run at significance level P 
value=0.001. Simpson’s diversity index (D) for geographical 
diversity was calculated using data from three datasets: (i) the 
current dataset (N=424), (ii) 489 L5 and L6 strains obtained 
from the sitvit2 database [49], a publicly available database 
that contains available genotyping (spoligotyping and Myco-
bacterial Interspersed Repetitive Units - Variable Number of 
Tandem Repeats), demographic and epidemiologic informa-
tion on 111 635 clinical isolates, and (iii) 837 genomes geno-
typed as L5 and L6 from 3580 strains from West Africa [28].
Antimycobacterial-resistance-determining mutations 
and genes
We have used a list of resistance mutations for 11 antibiotics 
compiled from two independent curated datasets [50] to 
determine genotypic antimycobacterial resistance. To deter-
minate drug- resistance differences between lineages L5 and 
L6 and geographical regions, univariate analysis using two- 
tailed Fisher’s exact test and multivariate logistic regression 
were performed with R- core packages. We compared any 
resistance (that is, having at least one resistance markers), 
and also resistance to three specific drugs independently 
(rifampicin, ethambutol and isoniazid independently, without 
considering other resistance markers). South Africa was not 
considered because it included only one genome.
RESULTS
New MTBC lineage: lineage 9
We analysed a total of 675 M. africanum genomes. These 
included 350 L5 and 320 L6 genomes, as well as 5 related 
genomes that could not be classified into any of the known 
human- or animal- associated MTBC lineages [4, 51]. Out 
of these 675 genomes, 641 (95 %) came from patient isolates 
originating in 1 of 21 countries of sub- Saharan Africa. 
Another 34 (5 %) strains were isolated outside of Africa from 
patients with an origin other than Africa or unknown (Table 
S1). To have a representative dataset and avoid overrepresen-
tation of clustered strains, we removed 251 isolates that were 
redundant, while keeping 95 % of the phylogenetic diversity 
(>95 % of the tree length) [40]. The resulting non- redundant 
dataset comprised 424 genomes and showed a similar country 
distribution compared to the original dataset (Fig. S1).
We first focused our analysis on the five genomes that could 
not be classified into any of the known MTBC lineages. To 
explore the evolutionary relationship of these five genomes in 
the context of M. africanum diversity, we reconstructed the 
phylogeny of the 424 M. africanum genomes together with 
a dataset of animal- associated MTBC genomes published 
previously [4]. The resulting phylogeny (Fig. 1) corroborated 
the separation of L5 and L6, and the localization of L6 in 
a monophyletic clade together with the animal- associated 
lineages [4]. To further explore the phylogenetic position of 
these five genomes, we reconstructed a phylogeny with 248 
reference genomes [52], including all eight human- associated 
lineages and four animal- associated clades (Fig.  2). The 
five unclassified genomes appeared as a sister clade of L6, 
branching between L6 and the animal clade A1 (Fig. 2). This 
L6 sister clade shared deletions with Lineage 6 such as region 
of difference (RD)702, but did not share other deletions 
present in animal- associated lineages such as RD1 and RD5.
The geographical origin of the five genomes differed from all 
other M. africanum genomes included in our analysis, as they 
were the only ones with an origin in East Africa (one from 
Djibouti, three from Somalia and one isolated in Europe but 
the patient origin was unknown). By contrast, all L5 and L6 
genomes came from isolates from West Africa (354 genomes) 
or Central Africa (37 genomes), except for 1 isolated from 
South Africa (Fig. 1) and 28 isolates from outside Africa and 
of unknown origin.
The five unclassified genomes showed the following in silico 
inferred spoligotype: 772000007775671 (nnnnnnonooooo
ooooooooooonnnnnnnnnnonnnonnnn) in the genome 
from Djibouti, 772700000003671 (nnnnnnononnnooooo
ooooooooooooooooonnnnonnnn) in all three Somalian 
genomes and a very similar pattern 772600000003631 
(nnnnnnononnooooooooooooooooooooooonnnnoonnn) 
in the genome from Europe. We searched for these three 
spoligotypes in the international genotyping database 
SITVIT2, which includes 9658 different spoligotypes from 
103 856 strains isolated in 131 countries [49]. Spoligotype 
772600000003631 was not found among the 103 856 strains 
included in the database, and the other two spoligotypes can 
be considered extremely rare because they have been found 
only in three strains in the database: 772000007775671 in 
a strain isolated in France, and 772700000003671 in two 
strains isolated in The Netherlands, although the patient’s 
origin is unknown.
The five unclassified genomes showed a mean distance of 
1191 SNPs to L6 genomes, 1632 SNPs to L5 genomes and 
1491 SNPs to the animal- associated MTBC genomes. Those 
distances were higher than the corresponding intra- lineage 
differences: 342 (sd 3.65) within L5, 542 (sd 9.19) within 
L6 and 332.4 (sd 14.48) within the unclassified genomes. 
When correcting for the diversity within each lineage, we 
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still found that the five unclassified genomes were sepa-
rated from the other lineages by 1 294, 582 and 654 SNPs 
of net distance to L5, L6 and the animal- associated line-
ages, respectively. The maximum genetic diversity within 
L9 was 514 SNPs, and occurred between strain G00075 
and strain G00074. Conversely, the smallest distance was 
99 SNPs between strain G04304 and strain G00075. Given 
the different geographical distribution and the substantial 
genetic separation with L6 genomes, we classified these five 
genomes into a new MTBC lineage that we propose to call 
MTBC lineage 9 (L9). The strain from L9 corresponding to 
genome G38445 will be submitted, adding to the original 
‘MTBC clinical strain reference set’ [53], to the mycobac-
teria culture bank of the Belgian Co- ordinated Collections 
of Micro- organisms (BCCM/ITM).
We looked for deleted regions in the L9 genomes that could 
be used as phylogenetic markers, as was done for other MTBC 
lineages in the past [6, 54, 55]. We identified one region deleted 
in all L9 genomes that spanned from Rv1762c to Rv1765. 
However, this region is not a robust phylogenetic marker 
because (i) Rv1763 and Rv1764 are putative transposases, 
and (ii) partially overlapping deletions can be found in other 
lineages. Specifically, Rv1762c was deleted in 'Mycobacterium 
orygis', and the region between Rv1763c and Rv1765 was 
deleted in L6 genomes. Hence, instead, we report a list of SNPs 
that can be used as phylogenetic markers for L9 (Table S2) 
given that they appear in all five L9 genomes and are absent 
from genomes from other lineages [40]. Given the low number 
of L9 genomes, we focused the remainder of our analysis on 
M. africanum L5 and L6.
Fig. 1. Maximum- likelihood phylogeny of 424 M. africanum genomes analysed together with animal- associated genomes used as 
references. Support bootstrap values are indicated at the nodes. The scale bar indicates the number of nucleotide substitutions per site. 
Nodes are coloured according to country or origin, and the shape of the node indicates susceptible or drug resistance based on absence 
or presence at least one of the drug- resistance mutations indicated in Table S8.
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Sublineages within L5 and L6
Our extended genomic analysis of L5 and L6 confirmed the 
deletions of the previously described RDs, including RD7, 
RD8, RD9 and RD10 [54, 55], and RD713 and RD715 [6], as 
indicated in the phylogeny (Fig. 1). However, the deletion of 
RD711 could not be confirmed as a L5 marker as proposed 
previously [6], as it was only deleted in a subset of L5 genomes, 
as reported recently [22]. We found RD711- deleted genomes 
to form a monophyletic clade within L5 (Fig. 1); named L5.1.1 
considering previous nomenclature as proposed by Ates et 
al. [22]. In contrast, RD702 was found to be deleted in all 
L6 strains, as shown previously [6], as well as in the newly 
defined L9 strains (Fig. 1).
Our phylogeny revealed a different topology for L5 compared 
to L6. Specifically, the L5 phylogeny showed little structure. 
Nevertheless, we subdivided L5 into three main sublineages 
that were well differentiated and highly supported by boot-
strap values >90, and named them consistent with previous 
nomenclature [22] as L5.1, L5.2 and L5.3. Due to the high 
genomic diversity within L5.1, this group was further subdi-
vided into five main sublineages (Fig. 1), leading to a total 
of seven L5 sublineages. Sublineage classification was only 
partially corroborated by the results of the PCA performed 
on whole- genome SNPs (Fig. 3a). By contrast, L6 showed a 
more differentiated population structure with three clearly 
differentiated monophyletic main sublineages (L6.1, L6.2 and 
L6.3) that could be further subdivided into at least three other 
sublineages each, to a total of nine L6 sublineages (Figs 1 and 
3b). The main three L6 sublineages L6.1, L6.2 and L6.3 were 
also clearly separated using PCA unlike the sub- divisions 
within each sublineage (Fig. 3b). To explore the robustness 
of the classification beyond PCA, we estimated genetic differ-
entiation for each of these sublineages using the fixation index 
(FST) based on Wright’s F- statistic [56] as a measure of popu-
lation differentiation due to genetic structure. We conducted 
a hierarchical analysis comparing the population structure at 
the two levels of subdivision: one level with the three main 
sublineages for both L5 and L6, and a second level with all 
seven and nine sublineages of L5 and L6, respectively. The 
L5 population structure showed the highest differentiation 
within all seven sublineages, where the highest population 
differentiation index FST=0.48 (P value <0.000001), and the 
lowest population differentiation index was found between 
the three main sublineages (FST=0.14, P value=0.04915). 
Similarly, FST between all seven L5 sublineages showed 
moderate differentiation with pairwise FST values between 
0.3 and 0.5 (Table S3), and net pairwise differences between 
76 and 206 SNPs (Table S4). Conversely, for L6, the higher 
differentiation was between the three main sublineages (L6.1, 
L6.2, L6.3, with 47 % of the variation, FST=0.47, P=0.0035), 
mirroring the PCA results. The differentiation between all 
nine sublineages of L6 was also stronger than for L5, with 
FST values ranging between 0.25 and 0.75 (Table S5), and 
net pairwise differences of between 73 and 493 SNPs (Table 
S6). A list of SNPs found exclusively in each of the L5 and L6 
sublineages is shown in Table S7.
In summary, different metrics point to a stronger population 
sub- division of L6 than L5. We propose to divide L6 in three 
main sub- lineages (L6.1, L6.2, L6.3), which in turn can be 
sub- divided in three sub- groups each (Fig. 1). For L5, we 
Fig. 2. Maximum- likelihood phylogeny of 5 unclassified genomes analysed together with a dataset of 249 MTBC genomes used as 
references. The five unclassified genomes are coloured in light green and tagged as L9. Animal- associated clades A1 to A4 are indicated 
and coloured in black. Support bootstrap values are indicated at the deepest nodes. The scale bar indicates the number of nucleotide 
substitutions per site.
7
Coscolla et al., Microbial Genomics 2021;7:000477
propose three new sub- groups within L5.1 [22] (Fig. 1) and a 
new main sublineage (L5.3).
Phylogeography
To explore the phylogeographical structure of L5, L6 and L9, 
we mapped the geographical origin of the genomes onto the 
phylogenetic tree as a coloured point at the end of each branch 
(Fig. 1). We grouped the different countries represented in the 
dataset into five regions in Africa: East, South and Central, 
and the Western part of West Africa (WWest Africa) and the 
Eastern part of West Africa (EWest Africa). We observed that 
most sublineages in L6 showed a characteristic geographical 
association at the regional level. At least five sublineages 
within L6 (all three L6.1 and two L6.2) showed a majority of 
genomes originating in wWest Africa, mostly The Gambia. By 
contrast, genomes from one sublineage within L6.2, from all 
three L6.3 sublineages and a few scattered L6 genomes from 
other sublineages came from EWest Africa, mostly Ghana. 
Only a few L6 strains were found in Central Africa (N=2) 
or outside Africa (N=15). However, we did not detect such 
phylogeographical structure for L5 sublineages, with most 
genomes originating in EWest Africa (mostly Ghana), just 
two sublineages (L5.2 and one sublineage within L5.1.1) in 
Central Africa and only a few dispersed genomes originated 
from WWest Africa.
To better understand the different geographical substructure 
within L5 and L6, we conducted an independent phylogeo-
graphical analysis using the GenGIS software, where each 
whole- genome SNP phylogeny was superimposed onto the 
five main African regions defined previously (Fig. 4a, c). If 
there is geographical separation, we expect the geographical 
distribution of the genomes to fit the phylogenetic tree 
structure. Fitting the tree is determined by finding a linear 
axis where the ordering of leaf nodes matches the ordering 
of sample sites according to the geographical distribution of 
each leaf node. If we draw a line between each leaf node in 
the phylogeny and its geographical distribution, a perfect 
match will result in minimum crossing of lines between the 
phylogeny and the map. Consequently, marked phylogeo-
graphical structure will result in significantly less crossing 
Fig. 3. PCA based on genomic variable SNPs. The PCA was conducted separately for L5 (a) and L6 (b). Colours indicate different 
sublineages and grey indicates genomes with no sublineage assigned ‘nolin’.
8
Coscolla et al., Microbial Genomics 2021;7:000477
than the number of crossings expected by chance. We found 
several orientations of the tree’s geographical axis resulting in 
less crossings than expected by chance in L6 (P <0.001, 10.000 
permutations; blue points below the red line in Fig. 4d). By 
contrast, for L5 we did not find less crossing than expected by 
chance (no blue points below the red line in Fig. 4b). These 
results indicate a marked geographical structure within L6, 
but not within L5.
To further confirm the different phylogeographical structures 
within L5 and L6, we calculated population differentiation 
indices considering each African region as a different popu-
lation for each lineage. This analysis revealed some phylo-
geographical substructure within L6, where the percentage 
of variation attributed to different regions within Africa was 
15 % (FST=0.15, P <0.00001). By contrast, L5 did not show 
any well- marked population differentiation, as the percentage 
of the variance attributed to population differences was 
only 6.6 %, with the rest of the variation attributed to intra- 
population differences (FST=0.036, P <0.00001). This result 
further supports the observation of higher geographical 
structure within L6 than L5.
Finally, we explored possible differences in geographical 
range. Our dataset was geographically biased because it was 
designed to assemble as many L5 and L6 genomes from 
as many countries as possible. Therefore, we analysed our 
genome dataset together with two other large datasets where 
samples were not genome sequenced but genotyped using 
spoligotyping, and compared the geographical distributions of 
L5 and L6 [28, 49]. This combined dataset included N=733 L5 
from 27 African countries and N=1031 L6 from 18 African 
countries. We expected that a broader geographical distribu-
tion of a specific lineage is associated with a lower probability 
that two individuals selected randomly will belong to the 
same country. We used the Simpson’s Index (D) to measure 
the probability that two individuals randomly selected from 
a sample will belong to the same country. We found a larger 
diversity of countries of origin in L5 than in L6 (D=0.16 vs 
D=0.27), indicating a broader geographical distribution of L5.
These results as whole indicate that L5 has generally expanded 
more within West Africa than L6. In the latter, the popula-
tion sub- division described in the previous section reflects 
a stronger association between phylogenetic groups and 
geographical regions reflecting more restricted expansions.
Ancestral geographical distribution of L5, L6 and L9
Next, we explored the most likely geographical origin of L5 
and L6 using four methods based on a Bayesian approach 
[43]. The probabilities of ancestral distribution areas for the 
principal nodes were always congruent with at least two 
methods, but the results of the two other methods were either 
Fig. 4. Phylogeographical structure in L5 and L6. Linear axis plot between the genomic phylogeny and the geographical origin of the 
genomes for L5 (a) and L6 (c), with minimum crossing between each leaf node in the phylogeny and its geographical distribution. 
Histograms show the number of crossing for each inclination of the axis, and the red lines indicate the number of crossings expected 
by chance for L5 (b) and L6 (d).
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inconclusive or showed minor discrepancies (Figs 5a and S2). 
For L5, two of the four methods inferred EWest Africa as the 
most likely origin (marginal probability was 1.0 using both 
Bayesian binary and s- diva), while the other two were incon-
clusive (marginal probabilities were EWest–Central, 0.94 and 
0.58 with BayArea and DEC, respectively; node 783 in Figs 5a 
and S2). For L6, two methods also pointed to EWest Africa as 
the most likely origin (0.77 and 1.0, of marginal probability 
using Bayesian binary and s- diva, respectively) and two 
methods supported both regions of West Africa as equally 
likely (0.94 and 0.58 using BayArea and DEC, respectively; 
node 592 in Figs 5a and S2). The ancestral distribution of L9 
was predicted to be East Africa based on all four methods 
(node 396 in Figs 5a and S2).
The ancestral distribution of the common ancestor between 
L6 and L9 was not confidently predicted because marginal 
probabilities supported similarly EWest Africa (0.65 and 0.57 
using BBM and DEC (node 591 Figs 5a and S2) and both 
regions within West Africa (0.5 using s- diva and BayArea). 
By contrast, the ancestral distribution for the common 
ancestor of L5, L6 and L9 showed more consistency, where 
EWest Africa was supported by three methods (0.74, 1.0 and 
0.57 using s- diva, BBM and DEC, respectively) and only one 
method predicting both EWest Africa and East Africa with 
a marginal probability of 0.99 (BayArea: node 784, Figs 5a 
and S4).
In summary, EWest Africa might have played an important 
role as the origin M. africanum L6 and L5, while L9 has a clear 
ancestral geographical distribution in East Africa. Although 
very strong statistical support is missing, our inferences point 
to a common ancestor of all M. africanum L5, L6 and L9 
initially originating in West Africa.
Differences in genetic diversity between lineages
In support of our previous findings based on a more limited 
dataset [57], we found that L6 was more genetically diverse 
than L5 with a significantly higher number of SNPs between 
pairs of sequences (median values 553 vs 321; P value 
<2.2×10−15), and significantly higher mean nucleotide diver-
sity (1.4×10−4 vs 8.7×10−5; P value <2.2×10−15). To explore 
whether this trend was consistent across the whole genome, 
we assessed the nucleotide diversity in different regions that 
might be under different selection pressures: essential genes, 
Fig. 5. Geographical ancestral distributions of L5, L6 and L9. (a) Ancestral area reconstruction by the Bayesian binary model onto the 
maximum- likelihood phylogeny. Circles represent the probabilities of ancestral ranges, and the most likely ancestral areas are indicated 
by their corresponding colour codes. (b) The four geographical areas considered in this analysis are coloured in the map, the most likely 
ancestral areas for each lineage are shown as stars, and movements of strains inferred from phylogeny indicated as arrows. The map 
was created using Mapchart (https://mapchart.net/africa.html).
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non- essential genes, antigens and T cell epitopes (Fig. 6). 
Although the genetic diversity was higher in all these different 
gene categories for L6 (Fig. 6), epitopes showed an inverted 
pattern in diversity between lineages (Fig. 6). Specifically, 
epitopes in L6 showed significantly higher genetic diversity 
than non- essential genes (Wilcoxon signed rank test P value 
<2.2×10−15), while the opposite was found for L5, with 
epitopes showing significantly lower genetic diversity than 
non- essential genes (Wilcoxon signed rank test P value 
<2.2×10−15).
Drug-resistance mutations
Antibiotic pressure is a strong selective force in bacteria 
including the MTBC. Hence, we explored the difference in 
drug- resistance determinants between L5 and L6. We found 
that among the 424 genomes analysed, 89 (21 %) showed at 
least one genetic marker of antimycobacterial- drug resistance, 
with 24 (6 %) being multi- drug resistant (defined as resist-
ance to at least isoniazid and rifampicin; Table S8). The most 
common resistance marker found was for streptomycin, with 
60 genomes showing 13 different resistance- conferring muta-
tions. The next most common was resistance to rifampicin 
and isoniazid, with 32 and 29 genomes, respectively. Addi-
tional resistance was found to ethambutol, fluoroquinolones, 
ethionamide, pyrazinamide and aminoglycosides (Table S8). 
L5 genomes were more likely than L6 genomes to carry muta-
tions associated with any resistance in a univariate analysis 
[odds ratio (OR) 1.76, 95 % CI 1.08–2.92, P value=0.0168], but 
that association disappeared once the different geographical 
regions were taken into account in a multivariable analysis 
(Table 1). In particular, EWest Africa genomes were associ-
ated with the presence of any resistances (OR 12.35, 95 % CI 
6.64–22.97, P value <0.001; Table 1), with rifampicin resist-
ance (OR 11.57, 95 % CI 4.54–29.47, P value <0.001; Table S9) 
and isoniazid resistance (OR 7.73, 95 % CI 3.15–17.00, P value 
<0.001; Table S9). Non- African genomes were associated 
with any resistances (OR 5.47, 95 % CI 2.43–13.52, P value 
<0.001; Table 1) and isoniazid resistance (OR 5.11, 95 % CI 
1.75–14.90, P value <0.001; Table S9). L5 was negatively asso-
ciated with resistance to rifampicin in a univariate analysis 
(OR 0.31, 95 % CI 0.11–0.78, P value=0.00924; Table S9), but 
Fig. 6. Nucleotide diversity (π). Comparison of pairwise nucleotide 
diversity (π) between L5 and L6 across gene categories
Table 1. Association of genotypic resistance (presence of at least one resistance marker to one drug) with lineages and geographical region
South Africa was not included because it includes one genome. * indicates reference category.
Lineage/region No. (%) with DR
(total N=87)
No. (%) with no DR 
(total N=580)
Univariate regression Multivariate regression
OR (95 % CI) P value OR (95 % CI) P value
Lineage
L6* 31 (35.6) 287 (49.5) – – – –
L5 56 (64.4) 293 (50.5) 1.76 (1.08–2.92) 0.0168 0.85 (0.48–1.50) 0.589
Region
WWest Africa* 34 (39.1) 465 (80.2) – – – –
Central Africa 7 (8.0) 49 (8.4) 1.95 (0.82–4.64) 0.129 2.11 (0.84–5.26) 0.108
EWest Africa 37 (42.5) 44 (7.6) 11.50 (6.57–20.11) <0.01 12.35 (6.64–22.97) <0.01
Non- African 9 (10.3) 22 (3.8) 5.59 (2.39–13.09) <0.01 5.74 (2.43–13.52) <0.01
DR, Drug resistance marker.
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not isoniazid (OR 0.71, 95 % CI 0.36–1.38, P value=0.222; 
Table S9). However, as before, these associations seem to be 
driven by geographical regions, as shown in the multivariate 
analysis (Table S9). Contrary to a previous report by Ates et al. 
[22], we found no evidence of differences in drug- resistance 
genotype between L5.2 and other L5 genomes (OR 1.21, 95 % 
CI 0.36–4.11, P value=0.49; Fisher’s exact test).
DISCUSSION
M. africanum has traditionally been considered a single entity 
and a separate species from what classically has been referred 
to as M. tuberculosis sensu stricto. The results presented here 
provide novel insights into the genomic particularities of 
the different lineages within M. africanum: L5, L6 and a new 
group described in this study, L9. Differences between these 
three lineages further emphasize the need to consider these 
lineages as separate phylogenetic and ecological variants 
within the MTBC.
Unexpectedly, our study of the global diversity of M. africanum 
revealed the presence of another MTBC lineage in Africa: 
L9, which is genetically close to L6. Unlike L5 and L6, which 
predominately occur in West Africa, L9 seems to be restricted 
to the East of Africa. Given that only five L9 isolates were 
included in our study, future studies are needed to confirm 
this observation [7, 8]. In this respect, L9 is similar to L7 and 
the recently described L8 [3], which are also mainly restricted 
to East Africa, but genetically more distant. L9 strains are 
also not part of a group of strains classified previously as M. 
africanum type II (East African clade), which belong to L4 
and were erroneously thought to be M. africanum [58]. We 
found clinical strains of L9 to be rare compared to L5 and 
L6, and this observation also resembles the situation for L7 
and L8. We cannot dismiss that this might be due to limited 
sampling, but the observation that clinical strains from L7, 
L8 and L9 originate in East Africa and are generally rare, 
while L5 and L6 are more prevalent and distributed across 
West and Central Africa, raises the question of whether the 
reduced prevalence of L7, L8 and L9 is due to biological 
reasons, or social- environmental causes that render L7, L8 
and L9 to be less successful. The lack of experimental and 
epidemiological data on L7, L8 and L9 impedes a profound 
discussion on the matter. However, the fact that L9 is geneti-
cally closer to L6 and L5 than to L7 and L8 speaks against a 
common intrinsic biological determinant shared by L7, L8 
and L9. Instead, convergence in the biology of the strains and/
or in the socio- demography of the host is a more likely driver 
of the evolutionary history of L7, L8 and L9.
Our phylogeographical analyses mostly suggested that the 
common ancestors of L5 and L6 lived in EWest Africa. We 
inferred that several subgroups of L5 moved from EWest Africa 
to Central Africa, while L6 subgroups moved mostly within 
West Africa. One of these events resulted in half of the L6 
genomes in our dataset representing strains that moved from 
EWest Africa to WWest Africa and with few dispersals back to 
EWest Africa (Fig. 5b). The ancestral reconstruction of L6 and 
L9 did not provide any clear signal, with EWest Africa and East 
Africa equally supported. For the ancestral distribution of all 
M. africanum, there was no consensus, but three out of four 
methods agreed on EWest Africa being the most likely place 
of origin. That would imply that L5 and L6 diversified there, 
and L9 migrated to East Africa. Because 'M. canettii', the most 
closely related species of M. tuberculosis is restricted to East 
Africa, we and others have proposed that East Africa is the 
likely origin of the MTBC [59–61]. If confirmed, the current 
geographical distribution of L5, L6 and L9 could be explained 
by a migration of their common ancestor from East Africa 
to West Africa, with the ancestor of L9 then moving back to 
East Africa. Unfortunately, the region of Central Africa is very 
poorly represented in our dataset. Possibly having more repre-
sentatives from this area, which makes the transition between 
East and West Africa, could bring new and relevant insights 
into the history of M. africanum and L9. Additionally, clade 
A1, due to its phylogenetic positioning, could potentially bring 
insights into the phylogeography of M. africanum. However, 
clade A1 as is currently known, contains only animal- adapted 
MTBC for which very few representatives are known. The 
geographical range of these non- human pathogens is poorly 
described, with one member (the ‘chimp bacillus’) isolated in 
West Africa, and the remaining members isolated in meer-
kats, mongooses and hyraxes in Southern Africa. As we have 
discussed in a previous work [4], probably the geographical 
range of these pathogens is broader than what is currently 
known, and including them in our geographical analysis 
would not inform particularly well our inferences and would, 
at the same time, put weight on Southern Africa.
The work presented here also demonstrates differences in the 
population structure of L5 compared to L6. While L6 showed 
a marked phylogenetic structure comprising distinct subline-
ages associated with different geographical regions, the clas-
sification of L5 into sublineages was not so clearly supported, 
despite the broader geographical range of L5 compared to 
L6. However, an independent study supported the split of 
L5.3 into L5.3.1 and L5.3.2 due to considerable gene content 
variability [62].
Our work confirms previous observations, where L6 shows a 
higher genomic diversity compared to L5 [57]. In particular, 
human T cell epitopes in L6 were more diverse than non- 
essential genes, while the opposite was true for L5. Several 
studies have shown that human T cell epitopes in the human- 
adapted MTBC are overall more conserved than non- essential 
genes [33, 63, 64]. This observation gave rise to the hypothesis 
that the MTBC might benefit from T cell recognition that 
drives lung pathology, leading to enhanced bacterial trans-
mission [65]. The fact that L6 differs in this respect from L5 
and the other human- adapted MTBC lineages indicates a 
potential different ecological niche, including possible animal 
reservoirs [12], which would also be supported by the phylo-
genetic proximity of L6 to the animal- adapted lineages of 
the MTBC (Fig. 1). Moreover, human TB caused by M. bovis 
compared to M. tuberculosis has also been associated with 
human immunodeficiency [66] and higher levels of immu-
nosuppression [67], which also suggest that L6 might be an 
opportunistic pathogen, similar to M. bovis in humans [68].
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We found L5 genomes more likely to carry any drug 
resistance- conferring mutations than L6 only in a univariate 
analysis. However, this observation was driven by genomes 
from Ghana, where L5 dominates. In univariate and multi-
variate analysis, genomes from EWest Africa, independently 
of lineage, were associated with genotypic resistance to any 
drug, rifampicin and also isoniazid resistance. Previous find-
ings from Ghana, found L5 associated to inhA promotor 
mutations conferring resistance to isoniazid compared to L4. 
However, in our study, we did not find L5 associated to inhA 
promotor region with isoniazid (OR 1.83, 95 % CI 0.46–7.84, 
Fisher exact test P value=0.37). In addition, contrary to the 
previous study from Ates et al. [22] based on a smaller dataset, 
our larger sampling indicated no association between drug 
resistance and a specific sublineage of L5 [22]. Our main study 
limitation is sampling bias, leading to an overrepresentation 
of isolates from the Gambia and Ghana. Consequently, drug- 
resistance genotype differences found are more likely to have 
been driven by a sampling bias of drug- resistance isolates 
in different countries rather than differences in control 
programmes.
The overrepresentation of genomes from the Gambia and 
Ghana could contort our observation regarding genomic 
diversity and population structure too. Moreover, including 
more genomes from other countries will likely reveal addi-
tional sub- lineages within L5 and L6.
In summary, we describe a large- scale whole- genome 
sequencing and a comprehensive phylogenomic analysis 
of clinical isolates classically referred to as M. africanum 
from 21 countries across Africa. Our findings have resolved 
hidden diversity, a complex evolutionary history and different 
patterns of variation between lineages. Our results contribute 
to a better understanding of the MTBC lineages restricted to 
parts of Africa. These findings might assist in unravelling the 
molecular signatures of adaptations, and inform the develop-
ment of targeted interventions for controlling TB in that part 
of the world.
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